Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lièvre A, Uronis H, Elimova E, Grootscholten C, Geboes K, Zafar S, Snow S, Ko AH, Feeney K, Schenker M, Kocon P, Zhang J, Zhu L, Lei M, Singh P, Kondo K, Cleary JM, Moehler M; CheckMate 577 Investigators. Kelly RJ, et al. Among authors: elimova e. N Engl J Med. 2021 Apr 1;384(13):1191-1203. doi: 10.1056/NEJMoa2032125. N Engl J Med. 2021. PMID: 33789008 Clinical Trial.
Anti-angiogenic agent ramucirumab: meaningful or marginal?
Wadhwa R, Elimova E, Shiozaki H, Sudo K, Blum MA, Estrella JS, Chen Q, Song S, Ajani JA. Wadhwa R, et al. Among authors: elimova e. Expert Rev Anticancer Ther. 2014 Apr;14(4):367-79. doi: 10.1586/14737140.2014.896207. Epub 2014 Mar 7. Expert Rev Anticancer Ther. 2014. PMID: 24605771 Review.
A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.
Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. Skinner HD, et al. Among authors: elimova e. Cancer. 2014 Dec 1;120(23):3635-41. doi: 10.1002/cncr.28911. Epub 2014 Aug 4. Cancer. 2014. PMID: 25091571 Free PMC article.
Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.
Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JA. Sudo K, et al. Among authors: elimova e. J Clin Oncol. 2014 Oct 20;32(30):3400-5. doi: 10.1200/JCO.2014.56.7156. Epub 2014 Sep 15. J Clin Oncol. 2014. PMID: 25225435 Free PMC article.
Medical management of gastric cancer: a 2014 update.
Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA. Elimova E, et al. World J Gastroenterol. 2014 Oct 14;20(38):13637-47. doi: 10.3748/wjg.v20.i38.13637. World J Gastroenterol. 2014. PMID: 25320502 Free PMC article. Review.
Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.
Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JA. Shiozaki H, et al. Among authors: elimova e. Oncology. 2015;88(6):332-6. doi: 10.1159/000368611. Epub 2015 Feb 28. Oncology. 2015. PMID: 25765098 Free PMC article.
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
Neishaboori N, Wadhwa R, Nogueras-González GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JA. Neishaboori N, et al. Among authors: elimova e. Oncology. 2015;89(2):65-9. doi: 10.1159/000371889. Epub 2015 Mar 5. Oncology. 2015. PMID: 25765719 Free PMC article.
83 results